Minocycline 100mg

DRUG4 trials

Sponsors

GlaxoSmithKline, Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico, University of Calgary, Zhongshan Ophthalmic Center, Sun Yat-sen University

Conditions

Clinically Isolated SyndromeInherited Retinal DystrophyMultiple SclerosisRetina DisorderRetinitis PigmentosaSchizophreniaSkin Infections (Acne)

Phase 1

Bioequivalence Minocycline Bioequivalence

CompletedNCT01755611

GlaxoSmithKlineSkin Infections (Acne)

Start: 2011-06-17End: 2011-06-25Updated: 2017-06-22

Phase 3

Minocycline in MS: Confirmation of Benefit

TerminatedNCT04291456

University of CalgaryClinically Isolated Syndrome, Multiple Sclerosis

Start: 2020-01-31End: 2022-12-31Updated: 2023-03-24

A Multicenter, Randomized, Double-Blind, Controlled Clinical Study of Minocycline for the Treatment of Retinitis Pigmentosa

Not yet recruitingNCT07082855

Zhongshan Ophthalmic Center, Sun Yat-sen UniversityInherited Retinal Dystrophy, Retina Disorder, Retinitis Pigmentosa

Start: 2025-07-15End: 2028-06-30Target: 126Updated: 2025-07-24

Phase 4

Anti-inflammatories and Adolescent Schizophrenia

Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, MexicoSchizophrenia

Start: 2019-02-25End: 2020-12-31Target: 90Updated: 2019-09-03